Cohance Lifesciences Ltd

BSE: 543064

41

total announcements

COHANCE.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 22 Oct 2026

Market Cap

₹17,668 Cr

P/E (TTM)

167.9

P/E (Forward)

47.6

EPS (TTM)

₹2.75

52W Low

₹266.70

52W High

₹903.40

Dividend Yield

0.00%

Beta

0.62

Price / Book

4.5

Debt / Equity

9.9

Revenue (TTM)

₹2,142 Cr

Gross Margin

70.36%

Operating Margin

-11.46%

AnnouncementsDiscussion
BSEBoard MeetingResults23 Jul 2026

Cohance Lifesciences Ltd

Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

Cohance Lifesciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 05/08/2026 to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter ended 30 June 2026.

Read more →📎 1 attachment
← PreviousPage 3 of 3